Montana counties pause J&J vaccines, per CDC and FDA advice

{{featured_button_text}} .tnt-restrict-img-c58491c5-3f53-5188-ace4-8cc9dcadb392 { max-width: 1654px; }

RiverStone Health hosts a COVID-19 vaccination clinic for MSU Billings students and staff on Monday. 

LARRY MAYER, Billings Gazette PAUL HAMBY

Montana health officials temporarily halted administering the single dose Johnson and Johnson vaccine for COVID-19 on Tuesday.

Local health departments joined those throughout the country in pausing doses until an investigation into whether the vaccine is linked to an exceptionally rare type of blood clotting is complete. Although Montana has utilized far more Pfizer and Moderna vaccines in immunizing its residents, the decision has delayed several clinics planned for the week.

The Centers for Disease Control and the Food and Drug Administration announced Tuesday morning that the agencies were reviewing six cases of severe blood clotting among the nearly seven million people who received the Johnson and Johnson vaccine. All six cases involved women aged 18-48 diagnosed with blood clotting in a portion of the brain about one to two weeks after getting vaccinated, according to a statement from the CDC and FDA.

Until each case can be reviewed, and the vaccine

View Source